Статус неизвестен
Фаза III
Россия
Myocet · Sopherion Therapeutics
A Phase III Randomized, Controlled Trial of Myocet, Trastuzumab and Paclitaxel Versus Trastuzumab and Paclitaxel for First-Line Therapy of Metastatic Breast Cancer